FOXA1 Is Required for Urothelial Differentiation and Its Loss in Bladder Cancer Is Associated With Poor Prognosis

被引：0
|
作者：
Reddy, Opal
Cates, Justin
Gellert, Lan
Crist, Henry
Yang, Zhaohai
Taylor, John
Smith, Joseph
Chang, Sam
Cookson, Michael
You, Chaochen
Barocas, Daniel
Grabowska, Magdalena
Ye, Fei
Wu, Xue-Ru
Matusik, Robert
Kaestner, Klaus
Clark, Peter
DeGraff, David
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Vanderbilt Univ, Nashville, TN 37235 USA
[3] Penn State Univ, Hershey, PA USA
[4] Univ Connecticut, Farmington, CT USA
[5] Univ Oklahoma, Oklahoma City, OK USA
[6] NYU, New York, NY USA
[7] Univ Penn, Philadelphia, PA 19104 USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1008
引用
收藏
页码：253A / 253A
页数：1
相关论文
共 50 条
  • [31] BREAST CANCER-ASSOCIATED SNPs AFFECT FOXA1 BINDING
    不详
    CANCER DISCOVERY, 2012, 2 (11) : 972 - 972
  • [32] FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes
    Elizabeth J. Adams
    Wouter R. Karthaus
    Elizabeth Hoover
    Deli Liu
    Antoine Gruet
    Zeda Zhang
    Hyunwoo Cho
    Rose DiLoreto
    Sagar Chhangawala
    Yang Liu
    Philip A. Watson
    Elai Davicioni
    Andrea Sboner
    Christopher E. Barbieri
    Rohit Bose
    Christina S. Leslie
    Charles L. Sawyers
    Nature, 2019, 571 : 408 - 412
  • [33] FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
    Joshua I. Warrick
    Wenhuo Hu
    Hironobu Yamashita
    Vonn Walter
    Lauren Shuman
    Jenna M. Craig
    Lan L. Gellert
    Mauro A. A. Castro
    A. Gordon Robertson
    Fengshen Kuo
    Irina Ostrovnaya
    Judy Sarungbam
    Ying-bei Chen
    Anuradha Gopalan
    Sahussapont J. Sirintrapun
    Samson W. Fine
    Satish K. Tickoo
    Kwanghee Kim
    Jasmine Thomas
    Nagar Karan
    Sizhi Paul Gao
    Timothy N. Clinton
    Andrew T. Lenis
    Timothy A. Chan
    Ziyu Chen
    Manisha Rao
    Travis J. Hollman
    Yanyun Li
    Nicholas D. Socci
    Shweta Chavan
    Agnes Viale
    Neeman Mohibullah
    Bernard H. Bochner
    Eugene J. Pietzak
    Min Yuen Teo
    Gopa Iyer
    Jonathan E. Rosenberg
    Dean F. Bajorin
    Matthew Kaag
    Suzanne B. Merrill
    Monika Joshi
    Rosalyn Adam
    John A. Taylor
    Peter E. Clark
    Jay D. Raman
    Victor E. Reuter
    Yu Chen
    Samuel A. Funt
    David B. Solit
    David J. DeGraff
    Nature Communications, 13 (1)
  • [34] FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
    Warrick, Joshua, I
    Hu, Wenhuo
    Yamashita, Hironobu
    Walter, Vonn
    Shuman, Lauren
    Craig, Jenna M.
    Gellert, Lan L.
    Castro, Mauro A. A.
    Robertson, A. Gordon
    Kuo, Fengshen
    Ostrovnaya, Irina
    Sarungbam, Judy
    Chen, Ying-bei
    Gopalan, Anuradha
    Sirintrapun, Sahussapont J.
    Fine, Samson W.
    Tickoo, Satish K.
    Kim, Kwanghee
    Thomas, Jasmine
    Karan, Nagar
    Gao, Sizhi Paul
    Clinton, Timothy N.
    Lenis, Andrew T.
    Chan, Timothy A.
    Chen, Zhiyu
    Rao, Manisha
    Hollman, Travis J.
    Li, Yanyun
    Socci, Nicholas D.
    Chavan, Shweta
    Viale, Agnes
    Mohibullah, Neeman
    Bochner, Bernard H.
    Pietzak, Eugene J.
    Teo, Min Yuen
    Iyer, Gopa
    Rosenberg, Jonathan E.
    Bajorin, Dean F.
    Kaag, Matthew
    Merrill, Suzanne B.
    Joshi, Monika
    Adam, Rosalyn
    Taylor, John A., III
    Clark, Peter E.
    Raman, Jay D.
    Reuter, Victor E.
    Chen, Yu
    Funt, Samuel A.
    Solit, David B.
    DeGraff, David J.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [35] Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients
    Jialiang Zhu
    Ziwen Lu
    Mang Ke
    Xianguo Cai
    International Urology and Nephrology, 2022, 54 : 1505 - 1512
  • [36] Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients
    Zhu, Jialiang
    Lu, Ziwen
    Ke, Mang
    Cai, Xianguo
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (07) : 1505 - 1512
  • [37] FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer
    C Gong
    K Fujino
    L J Monteiro
    A R Gomes
    R Drost
    H Davidson-Smith
    S Takeda
    U S Khoo
    J Jonkers
    D Sproul
    E W-F Lam
    Oncogene, 2015, 34 : 5012 - 5024
  • [38] FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome
    Schrijver, Willemijne
    Schuurman, Karianne
    van Rossum, Annelot
    Droog, Marjolein
    Jeronimo, Carmen
    Salta, Sofia
    Henrique, Rui
    Wesseling, Jelle
    Moelans, Cathy
    Linn, Sabine C.
    van den Heuvel, Michel
    van Diest, Paul
    Zwart, Wilbert
    MOLECULAR ONCOLOGY, 2018, 12 (11) : 1884 - 1894
  • [39] FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer
    Gong, C.
    Fujino, K.
    Monteiro, L. J.
    Gomes, A. R.
    Drost, R.
    Davidson-Smith, H.
    Takeda, S.
    Khoo, U. S.
    Jonkers, J.
    Sproul, D.
    Lam, E. W-F
    ONCOGENE, 2015, 34 (39) : 5012 - 5024
  • [40] Retraction Note: Overexpression of ROCK1 promotes cancer cell proliferation and is associated with poor prognosis in human urothelial bladder cancer
    Yanhui Mei
    Yuhai Wu
    Longbo Ma
    Hongli Zhang
    Lei Li
    Feng Wang
    Mammalian Genome, 2023, 34 : 3 - 3
12345